Can Definitive Healthcare Corp. (DH) Maintain Stability After Revised Price Target From Baird?

Laiba Immad

Tue, May 19, 2026 at 7:08 AM EDT 2 min read

We recently compiled a list of the 10 Best Penny Stocks Under $1 According to Hedge Funds. Definitive Healthcare Corp. (NASDAQ:DH) is among the best penny stocks on this list.

TheFly reported on May 8 that Baird reduced its price target on DH to $1.10 from $1.30 in a revised outlook, while a Neutral rating was maintained. The adjustment came after the firm refreshed its financial model in response to the company’s first-quarter performance.

On May 7, Definitive Healthcare Corp. (NASDAQ:DH) released its first-quarter 2026 results for the period ended March 31, 2026, reporting revenue of $55.9 million, down 6% from $59.2 million a year earlier. The company recorded a net loss of $192.4 million, which included significant goodwill impairment charges, compared with a $155.1 million loss in the prior-year quarter.

The company’s Adjusted profitability showed improvement, with adjusted net income of $8.5 million versus $7.0 million, and adjusted EBITDA rising to $15.3 million, or 27% of revenue, compared with $14.7 million and 25% previously. Cash flow from operations reached $11.6 million, while unlevered free cash flow totaled $18.0 million. Looking ahead, the business issued second-quarter and full-year 2026 guidance, projecting stable revenue trends alongside continued adjusted profitability and EBITDA margin expansion supported by operating efficiency and disciplined cost management.

Definitive Healthcare Corp. (NASDAQ:DH) is a SaaS healthcare data company based in Framingham. It provides analytics on healthcare providers and claims to help clients improve sales, marketing, and market research.

While we acknowledge the potential of DH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 8 Most Oversold Large Cap Stocks to Buy and 10 Best Cancer Stocks to Buy for the Long Term. 

Disclosure: None. Follow Insider Monkey on Google News.